Elanco Animal Health

Elanco Animal Health

Yahoo Finance • 11 days ago

Citi's picks and pans for H2 '26: REITs, tech, consumer, health

[Citibank headquarters in Canary Wharf, London, UK] VV Shots Citi released its roadmap for the second half of 2026, including a macro-to-micro view of equity sectors. "Our recently revised S&P 500 (SPY [https://seekingalpha.com/symbol/SP... Full story

Yahoo Finance • 23 days ago

1 Mid-Cap Stock to Own for Decades and 2 We Question

1 Mid-Cap Stock to Own for Decades and 2 We Question Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of... Full story

Yahoo Finance • 24 days ago

BioHeartland Indiana Debuts at BIO 2026, Showcasing Indiana's Global Bioscience Leadership

New regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs. INDIANAPOLIS, June 22, 2026 /PRNewswire/ -- Today at BIO International Convention in San Diego, th... Full story

Yahoo Finance • last month

1 Profitable Stock to Target This Week and 2 We Avoid

1 Profitable Stock to Target This Week and 2 We Avoid Even if a company is profitable, it doesn't always mean it's a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their futu... Full story

Yahoo Finance • last month

Elanco Animal Health Announces USDA Approval Of TruCan Ultra Lyme-L4

(RTTNews) - Elanco Animal Health (ELAN) announced the U.S. Department of Agriculture approval of TruCan Ultra Lyme-L4. It is the first and only 1/2 mL combination vaccine protecting against both Lyme disease and leptospirosis, all in a low... Full story

Yahoo Finance • last month

2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cash flow is valuable, but it’s not everything - StockStory helps you identify the c... Full story

Yahoo Finance • last month

Cattle Prices Are a Problem for Tyson and JBS Stock. Could New World Screwworm Make Things Worse?

The parasitic fly has been detected in the U.S. for the first time in 60 years, putting pressure on an already shrinking cattle population. Continue Reading... Full story

Yahoo Finance • 2 months ago

Monumental Public-Private Initiative Forms to Permanently Close America's Protein Gap

America's Farmers, Protein Industry, Hunger Advocates Launch $40 Million Initiative to Deliver 3 Billion Protein-Rich Meals Annually NORTHAMPTON, MA / ACCESS Newswire / May 27, 2026 / On the eve of World Hunger Day, a broad-based coalitio... Full story

Yahoo Finance • 2 months ago

What to Know About This Fund's $85 Million Lionsgate Buy During a Breakout Quarter

On May 15, 2026, Shapiro Capital Management disclosed a new position in Lionsgate Studios(NYSE:LION), acquiring 9,309,570 shares in an estimated $85.91 million trade based on quarterly average pricing. What happened According to a Securi... Full story

Yahoo Finance • 2 months ago

Elanco (ELAN) Q1 2026 Earnings Transcript

Image source: The Motley Fool. Date Wednesday, May 6, 2026 at 8:00 a.m. ET Call participants President & CEO — Jeffrey N. Simmons Executive Vice President & CFO — Robert VanHimbergen Need a quote from a Motley Fool analyst? Email pr@f... Full story

Yahoo Finance • 3 months ago

Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Jazz Pharmaceuticals (NASDAQ:JAZZ) and the best and worst performers in the pharma... Full story

Yahoo Finance • 3 months ago

National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer

AUSTIN, Texas, April 24, 2026--(BUSINESS WIRE)--National Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company’s executive leadership team... Full story

Yahoo Finance • 3 months ago

Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026?

Quick Read Zoetis (ZTS) received a Buy rating and $145 price target from Citi as top pick in animal health, citing the humanization of pets driving pain management spending in a market where 40% of dogs and cats suffer from osteoarthritis... Full story

Yahoo Finance • 4 months ago

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 4 months ago

Moderna stands as the best performing large-cap healthcare stock YTD

[Heart Health Concept] Eoneren/E+ via Getty Images U.S. large-cap healthcare stocks have delivered modest year-to-date gains in 2026, holding steady into March amid its defensive appeal. Below is a list of the top 10 large-cap healthcare... Full story

Yahoo Finance • 4 months ago

1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry... Full story

Yahoo Finance • 4 months ago

Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains?

Elanco Animal Health Incorporated (ELAN) shares soared 7.6% in the last trading session to close at $25.18. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.9%... Full story

Yahoo Finance • 4 months ago

Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?

Elanco’s 26.6% return over the past six months has outpaced the S&P 500 by 23.6%, and its stock price has climbed to $23.47 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering... Full story

Yahoo Finance • 5 months ago

Jim Cramer Highlights Elanco’s “Comeback Story”

Elanco Animal Health Incorporated (NYSE:ELAN) is one of the stocks Jim Cramer commented on. Cramer highlighted the stock’s terrific performance over the last 12 months, as he commented: I love a good comeback story. Right now, there’s a g... Full story

Yahoo Finance • 5 months ago

Elanco Animal Health Incorporated Q4 2025 Earnings Call Summary

Elanco Animal Health Incorporated Q4 2025 Earnings Call Summary - Moby Strategic Performance Drivers Achieved 9% organic constant currency revenue growth in Q4, marking 10 consecutive quarters of underlying growth led by U.S. farm and pe... Full story